Balance, Fall Risk, and Gait in Women With Total Knee Arthroplasty
NCT07650175
Balance, Postmenopausal Women
View Trial DetailsNCT Number: NCT06972017
Emergency General Surgery (EGS) is an umbrella term which describes all patients presenting to hospital with an acute abdominal problem. Patients can have various conditions requiring emergency operations. EGS is one of the most common reasons for an emergency admission in the UK.
EGS is often referred to as "high-risk" surgery. For those patients who do survive after their surgery, many struggle with frailty and new medical problems resulting in a reduction in their quality of life (QoL).
The goal of this observational study is to explore QoL and decision-making in EGS through questionnaires and interviews with patients, families/supporters and consultants working in EGS.
Workstream 1 will involve patients and families/supporters. Workstream 2 will involve consultants.
The investigators are interested in patients who have either undergone EGS (EmLaps) or have needed but not undergone EGS (NoLaps). The investigators are interested in exploring participants (patients, families/supporters and consultants) experiences of this EmLap vs NoLap decision.
The main questions the investigators want to answer are:
* What is the long-term QOL of EmLap/NoLap patients and their family/supporters? * How do patients and their family/supporters describe their experience of decision-making in EGS? * What are consultant's experiences and views on decision-making in EGS?
Workstream 1 participants (patients and family members/supporters) will complete questionnaires and take part in interviews at different time-points following their decision (1 month/3 months/ 9-12 months). Questionnaires and interviews will explore QoL and decision-making in EGS.
Consultant participants will be asked to complete an online survey and/or take part in an individual interview. Both will explore decision-making in EGS.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Group 1 and 2: EmLap and NoLap patients (up to 30 participants)
Patient inclusion/exclusion criteria should mirror NELA inclusion/exclusion criteria and NELA NoLap guidelines. NELA is the "National Emergency Laparotomy Audit" which recruits patients in Wales and England and there inclusion/exclusion criteria are widely accepted for use in Emergency General Surgery research.
Inclusion criteria
Exclusion criteria
Group 3: Families/Supporters (up to 30 participants) Inclusion criteria
Exclusion criteria
Group 3: Consultants (interview:12-20 participants/survey: minimum 52 participants) Inclusion criteria
Exclusion criteria
Time frame: 1 year
The primary aim of workstream 1 is to report on the long-term QoL of EmLap and NoLap patients and their families/supporters. For this, participants will complete validated QoL questionnaires within 4 weeks of EmLap/NoLap decision then again at 3 and 9-12 months post-decision.
Questionnaires will include European Quality of Life 5 Dimensions 5 Level Version (EQ-5D-5L) which will specifically quantify QoL. Maximum score= 1. Minimum scores in the UK have been reported at -0.28. A higher score reflects a higher QoL.
Time frame: 1 year
The primary aim of workstream 2 is to describe and explore consultant experiences of decision-making in EGS through online survey and semi-structured interviews.
Time frame: 1 year
Semi-structured interviews with patients and families/supporters will allow us to explore their experience and views of decision-making in EGS.
Time frame: 1 year
Workstream 1 will clarify which specialties are involved in the EGS decision-making process to allow recruitment for workstream 2.
We will specifically clarify the number of EGS decisions which involve
Time frame: 1 year
The results from workstream 1 will inform the development of PROMs for EGS. These PROMS will include a number of specific EGS related questions developed from our study results.
Time frame: 1 year
The results from workstream 1 will inform the development of PREMs for EGS. These PREMS will include a number of specific EGS related questions developed from our study results.
Contact information is provided by the study sponsor or research team.
Rachel John-Charles, MBChB, Bsc (Hons), MRSC
CONTACT
Susan Moug, MBChB, Bsc (Hons), FRSC, PhD
CONTACT
NHS Greater Glasgow and Clyde
Other
Acronym: PERI-SCOPES
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07650175
Balance, Postmenopausal Women
View Trial DetailsNCT07320820
Agnosia, Anxiety Depression
View Trial DetailsNCT07415850
Anxiety, Anxiety Disorders
Villanova, Pennsylvania, United States
View Trial DetailsNCT07346469
Chemotherapy Induced Peripheral Neuropathy (CIPN), Colonic Diseases
Kaohsiung City, Sanmin District, Taiwan
View Trial Details